5 Year Evolution of PCI vs CABG in Large Randomized Studies on Acute and Chronic Coronary Syndrome

Left main lesions in acute coronary syndrome (ACS) represent a major risk and, at present, the best revascularization strategy is a matter of debate. Though many studies and registries have excluded this group of patients, there is data on the pros and cons of both percutaneous coronary intervention (PCI) and cardiac artery bypass graft (CABG). 

Evolución a 5 años de la angioplastia vs cirugía en los grandes estudios sobre síndromes agudos y crónicos

This analysis looked at 4 randomized studies comparing PCI with drug eluting stents (DES) vs. CABG (SYNTAX, PRECOMBAT, NOBLE and EXCEL) including a total of 1,466 patients (33.4%) with SCA and 2,927 without SCA (NSCA).

Primary end point was all cause mortality at 5 years. Mean age was 65 and most patients were men. There were no significant differences between the groups, except for a higher prevalence of diabetes, prior MI, ejection fraction <50 and higher SYNTAX score, among SCA patients (26.4 vs. 25.2; p < 0.001).

Time from randomization to procedure was shorter in patients undergoing PCI.

At 30 days, there was higher cardiovascular and non-cardiovascular mortality in SCA patients vs. NACS (1.8 vs. 0.5 p<0.001 AND 1.9 vs. 0.5 p<0.001 respectively).

MI rate was higher in ACS patients both at one and five year followup (2.3% vs. 1.0%; HR 2.73, 95% CI ;1.63-4.58; p < 0.001 and 5.7% vs. 3.8%; HR 1.70, 95%CI: 1.25-2.31; p < 0.001, respectively).

Read also: Minimal Stent Area: New IVUS Parameter?

MI rate was higher in ACS patients both at one and five year followup (2.3% vs. 1.0%; HR 2.73, 95% CI ;1.63-4.58; p < 0.001 and 5.7% vs. 3.8%; HR 1.70, 95%CI: 1.25-2.31; p < 0.001, respectively).

Primary end point resulted similar with PCI for both ACS and NACS patients (10.9% vs 11.5% HR, 0.93; 95% CI, 0.68-1.27 and 11.3%vs 9.6% HR, 1.19; 95% CI, 0.95-1.50 respectively). There was a lower rate of stroke in the PCI group, but this group also showed higher need for repeat revascularization or MI vs. CABG patients. 

Conclusion

Among patients undergoing left main revascularization with low to intermediate coronary anatomical complexity, patients presenting ACS had a higher rate of early mortality. However, 5-year mortality was similar between PCI and CABG. In the short term, PCI had a relative advantage over CABG in terms of stroke. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes. A Pooled Analysis of 4 Randomized Clinical Trials

Reference: Prakriti Gaba, et al. JAMA Cardiol. doi:10.1001/jamacardio.2023.1177.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...